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Seroepidemiology of Hepatitis A in Korea: Changes over the Past 
30 Years
This study aimed to assess the immune status of the Korean population against hepatitis A 
virus (HAV). Residual serum samples from 2008 to 2010 were collected from diagnostic 
laboratories and a total of 1,872 samples were analyzed. Anti-HAV seroprevalence was 
57.3% in subjects aged 1-4 yr, 69.8% at 5-9 yr and decreased to 38.8% at 10-14 yr, 
13.0% at 15-19 yr, and 11.7% at 20-29 yr. Seroprevalence increased with increasing age: 
52.2% at 30-39 yr, 83.2% at 40-49 yr, 81.4% at 50-59 yr, 93.2% at 60-69 yr, and 
95.1% at 70-79 yr. The most susceptible age group consisted of subjects aged 10-29 yr, 
especially those aged 20-29 yr. This pattern is markedly different from that in the past 3 
decades, where the most susceptible group had consisted of children aged less than 10 yr 
and almost all subjects aged more than 20 yr had developed anti-HAV antibodies. Because 
of improvements in hygiene and introduction of hepatitis A vaccine, the age demographic 
of the susceptible population has shifted. These data are important for creating new 
prevention measures, including vaccination policies, to prevent and control outbreaks of 
hepatitis A in Korea.
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INTRODUCTION
Hepatitis A occurs throughout the world with major differences 
in geographical endemicity and clinical characteristics (1). The 
patterns of hepatitis A virus (HAV) infection are closely related 
with hygiene and socioeconomic status. Over the past several 
decades, the epidemiology of hepatitis A has shown dynamic 
changes in Korea. Up to the early 1980s, Korea was classified as 
a high endemic country, with most cases occurring in young 
children (2-4). With improvements in sanitation and socioeco-
nomic conditions, opportunities for exposure decreased, lead-
ing to an increase in susceptible populations among adolescents 
and young adults. This resulted in several outbreaks since 1996 
(5-7). Korea is currently at a transitional status from a high to low 
endemicity, resulting in an increase of disease burden on pub-
lic health.
  Fortunately, a safe and highly efficacious vaccine exists for 
hepatitis A, providing an opportunity to lower disease incidence 
and potentially eliminate infection (3). In Korea, the vaccine was 
first introduced in 1997 and has been recommended for high-
risk groups and is currently recommended in children over 12 
months of age. Although hepatitis A vaccine is not yet included 
in the national immunization program, the number of vacci-
nated people is increasing with the growing social recognition 
of the disease.
  To develop appropriate immunization strategies an integrat-
ed evaluation of the epidemiology of hepatitis A is important. In 
this study, we aimed to evaluate the seroprevalence of hepatitis 
A in Korea in order to assess the immune status of the Korean 
population and find susceptible age groups. We also reviewed 
previous seroprevalence studies performed in the past 30 yr to 
enhance our understanding of the dynamics of these changing 
epidemiology.
 
MATERIALS AND METHODS
Sample collection
Sera were collected from two diagnostic laboratories located in 
Seoul, Korea. One laboratory has a network of laboratories lo-
cated in provinces throughout Korea. Residual serum samples 
after diagnostic testing, which would otherwise have been dis-
carded were collected. Sera referred for the diagnosis of infec-
tious diseases such as measles, mumps, rubella, hepatitis A and 
HIV were excluded. 
  Samples were collected from February 2008 to March 2010. 
In order to keep anonymity, subject information was deleted 
and sera were assigned with a new code number. The only de-
mographic characteristics available were age, gender, district of 
laboratory and date of sampling.
  Serum samples were collected from subjects aged 1-79 yr. Sam-Lee H, et al.  •  Seroprevalence of Hepatitis A in Korea
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ples were stratified into the following age groups: 1-4, 5-9, 10-14, 
15-19, 20-29, 30-39, 40-49, 50-59, 60-69, and 70-79 yr. Subjects 
from 1-9 yr of age were also analyzed in 1 yr unit, and seroprev-
alence was analyzed by 2 yr unit in subjects 10-29 yr. 
Sample size calculation
The sample size was calculated using the following equation:
n = z
2
α/2p(1-p)/d
2
zα/2: 1.96 standard deviation, d: precision (= confidence inter-
val/2), p: prevalence, α: type I error.
Prevalence was based on a previous report of seroprevalence of 
hepatitis A antibodies in Korea (8). 
Hepatitis A antibody analysis
Serum samples were tested to detect anti-HAV (Elecsys
® 2010/
Modular analytics E170, Roche Diagnostics GmbH, Indianapo-
lis, IN, USA). 
Literature search
We searched the MEDLINE, KoreaMed, and the Korean Medi-
cal Database for studies of hepatitis A seroprevalence in Korea. 
The search included terms in the title or key words ‘Hepatitis A’, 
‘Seroprevalence’, and ‘Hepatitis A vaccine’. A manual search 
was also done on studies referenced in publications identified 
through the initial search.
Data collection
We reviewed all studies that reported seroprevalence against hep-
atitis A in Korean subjects. Studies of seroprevalence in selected 
age groups or populations such as soldiers, police officers, hos-
pital personnel etc. were excluded. Studies regarding patients 
with acute or chronic liver disease were also excluded. Data from 
each of the studies with a similar age classification of our study 
were extracted by age group for comparison.
Ethics statement
The study proposal was approved by the Institutional Review 
Board at Ewha Womans University Mokdong Hospital (#203-2) 
in Seoul, Korea.
RESULTS
Seroprevalence of Hepatitis A
A total of 2,061 sera were collected; of these, 1,872 of sufficient 
amount were tested. Among the sera tested, 43.7% (818/1,872) 
were from male patients, and there was no difference in serop-
revalence between gender groups (male 54.4%, female 52.0%). 
Seropositivity according to age group is shown in Table 1. The 
total seroprevalence against HAV was 53.8%. When analyzed 
according to age, the seroprevalence showed a sinusoidal wave 
pattern (Fig. 1). In subjects aged less than 10 yr, seropositivity was 
also separately analyzed by 1 yr unit. Seropositivity in infants 
was 26.3% and increased to 56.3%-83.9% in children 2-9 yr of 
age. The seropositivity in subjects aged 10-11 yr was 38.8% and 
decreased to 9.5% in subjects of the early twenties. Seropositivi-
ty then gradually increased from 43.3% in subjects aged 30-34 
Table 1. Seroprevalence against hepatitis A in Korea, 2008-2010
Age (yr) No. tested No. positive  % positive (95% CI)
1-4 410 235   57.3 (54.9-59.7)
5-9 400 279   69.8 (67.5-72.1)
10-14 139 54   38.8 (34.7-43.0)
15-19 138 18   13.0 (10.2-15.9)
20-29 206 24 11.7 (9.5-13.9)
30-39 301 157   52.2 (49.3-55.1)
40-49 119 99   83.2 (79.8-86.6)
50-59 59 48   81.4 (76.3-86.5)
60-69 59 55   93.2 (89.9-96.5)
70-79 41 39   95.1 (91.8-98.5)
Total 1,872 1,008   53.8 (53.7-55.9)
No., number; CI, confidence interval.
Age (yr)
70-79
65-69
60-64
55-59
50-54
45-49
40-44
35-39
30-34
28-29
26-27
24-25
22-23
20-21
18-19
16-17
14-15
12-13
10-11 9 8 7 6 5 4 3 2 1
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Fig. 1. Age specific seroprevalence against hepatitis A in Korea.Lee H, et al.  •  Seroprevalence of Hepatitis A in Korea
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yr to 60.9% in subjects aged 35-39 yr, 83.2% in subjects aged 40-
49 yr, and 95.1% in subjects aged 70-79 yr.
Changes in seroprevalence of Hepatitis A over the past 30 yr
The data from studies performed in Korea were reviewed (Table 
2) (7-21). Patterns in seroprevalence according to age groups 
showed distinct changes over the past 30 yr (Fig. 2) (8, 9, 15). Fig. 
2A shows changes in seroprevalence over different periods of 
time (10-yr intervals) according to age group. From 1979 to 1981, 
almost all subjects over 20 yr of age were seropositive against 
HAV. At that time, in subjects younger than 20 yr of age, serop-
revalence increased with age: 22% at 1-4 yr old, 59.1% at 5-9 yr 
old and 87% at 10-19 yr of age. Ten years later, from 1988 to 1989, 
the seropositive rate gradually decreased in children and ado-
lescents under 20 yr of age. This decrease in seroprevalence con-
tinued during the following 10 yr in 1996-1997 along with a sub-
tle decrease in seropositive rates in subjects 20-29 yr of age. In 
2006, the seroprevalence pattern showed changes in the 1-4 and 
5-9 yr old age groups: an increase from 7% to 55.6% in subjects 
aged 1-4 yr and from 2% to 47.2% in subjects aged 5-9 yr. How-
ever, in subjects older than 10 yr old, the decreasing trend in se-
roprevalence continued with an especially sharp decline in se-
roprevalence among subjects 20-29 yr of age.
  The differences in seroprevalence among age groups over the 
past 30 yr are shown in Fig. 2B. The seroprevalence curve in 1979-
1981 shows a steep increase in seropositivity among subjects 
aged 1-4 yr up to 20 yr. In 1988-1989, subjects in the 1-4 and 5-9 
yr age groups showed a subtle increase in seropositivity com-
pared with that 10 yr before (in 1979-1981); however seroposi-
tivity again showed significant increase in the 10-19 yr old group. 
In 1996-1997, seropositivity among subjects 5-9 yr of age was 
lower than that among subjects 1-4 yr of age, and the seroprev-
alence curve showed a U pattern. This pattern changed to a si-
nusoidal shape in 2006 and again in 2008-2010. Another impor-
tant finding is that over the past 30 yr, the seroprevalence curve 
shifted toward the right, showing a change in susceptible age 
group for infection from children under 10 yr of age to subjects 
10-29 yr of age.
Table 2. Hepatitis A seroprevalence studies in Korea
Study (Reference No.) Survey year Area Total sera Age (yr)
Hong WS et al. (9) 1979-1981 Seoul 388 0-79
Kim TW et al. (10) 1980-1981 Chungnam 455 0-19
Lee JI et al. (11) 1981 Chungnam 543 0-80
Lim DS et al. (12) 1989 Chungbuk 802 0-≥ 70
Lee KY et al. (13) 1996-1997 Daejeon, Chungnam 722 0-≥ 70
Choi W et al. (7) 1996-1997 Seoul, Incheon 2,401 16-77
Sohn YM et al. (14) 1996 Gyeonggi 344 0-19
Park CH et al. (15) 1988-1997 Gyeongnam (Jinju) 2,737 0-69
Kim TY et al. (16) 2002-2006 Seoul, Gyeonggi 4,299 0-50
Kwon YO et al. (17) 2004-2005 Busan 472 2-50
Choi HJ et al. (18) 2005 Incheon, Gyeongnam 1,301 0-50
Song YB et al. (19) 2006 Seoul 250 20-69
Kim JH et al. (8) 2006 Seoul, Incheon, Gyeonggi, Daegu 1,076 0-69
Lee DH et al. (20) 2005-2009 Throughout Korea 45,296 0-≥ 60
Moon HW et al. (21) 2009 Seoul 3,127 0-≥ 60
No., number.
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Fig. 2. Changes of seroprevalence against hepatitis A in Korea from 1979 to 2010 (data from reference no. 8, 9, 15). (A) Changes over different periods (10-yr intervals) ac-
cording to age group, (B) Changes among age groups over the past 30 yr.
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DISCUSSION
There has been a clear change in seroprevalence patterns in Ko-
rea over the past 30 yr. The susceptible population has changed 
from subjects under 10 yr of age to subjects 10-29 yr of age. The 
susceptible proportion of subjects aged 30-39 yr and 40-49 yr is 
also gradually increasing. The changes in seroprevalence coin-
cide with several environmental factors. A main influencing 
factor is that the socioeconomic status of Korea has shown steady 
improvement over the past 30 yr, accompanied by an improve-
ment in individual and social hygiene. Considering that hepati-
tis A is transmitted through the fecal-oral route, either by per-
son-to-person contact or by ingestion of contaminated food or 
water, improvements in sanitation has led to big changes in the 
epidemiology of this disease in Korea. The epidemiology of hep-
atitis A can be classified into high, intermediate, low, and very 
low endemicity (1, 3). In areas of high endemicity, infection gen-
erally occurs in early childhood, when most cases can be asymp-
tomatic or unrecognized, and most of the population is infected 
before reaching adolescence (22). The seroprevalence pattern 
in 1979-1981 in Korea represents typical characteristics of a high 
endemic area. In areas of intermediate endemicity, improve-
ments in sanitation and living conditions leads to lower trans-
mission of HAV and the predominant age group of infection con-
sists of school-aged children, adolescents, and young adults. 
Paradoxically, the overall incidence of reported cases is often 
higher than that in highly endemic areas because the suscepti-
ble population is more likely to develop symptoms of HAV infec-
tion. Large outbreaks occur because of high rates of virus trans-
mission and large numbers of susceptible persons. Seropreva-
lence curves from 1996 to 1997 and afterwards in Korea reflect 
changes toward an intermediate endemic area. In low endemic 
countries, disease incidence is generally low, and many cases 
are associated with travelers from regions of high or intermedi-
ate endemicity.
  Another important factor regarding the change in prevalence 
patterns is the introduction of the hepatitis A vaccine in Korea. 
The seroprevalence pattern changed from a U shape to a sinu-
soidal shape with an increase in percentage of children under 
10 yr old with anti-hepatitis A antibody. After introduction of the 
hepatitis A vaccine in Korea in 1997, high-risk groups were vac-
cinated, and children over 12 months of age were immunized 
on a private basis. With the introduction of the hepatitis A vac-
cine, seroprevalence increased from 7% to 57.3% in subjects 1-4 
yr of age and from 2% to 69.8% in subjects 5-9 yr of age from 1996-
1997 to 2008-2010.
  The changes observed in hepatitis A seroprevalence patterns 
reflect the changes in hepatitis A disease patterns in Korea. Since 
the large epidemic in Daejeon (13), outbreaks are continuing in 
the country. Data regarding population-based incidence is lim-
ited in Korea; however hepatitis A is included in the national sen-
tinel surveillance system which was started in 2001. According 
to the surveillance system, 312-355 cases were reported in 2002-
2004. The number of cases doubled to 798 in 2005, increased to 
2,081-2,233 in 2006-2007, 7,895 in 2008, and 15,231 in 2009. When 
stratified by age group, cases increased throughout all age groups 
with only a subtle increase in children 0-9 yr of age. However, 
the number of cases involving 20- to 29-yr-olds increased from 
147 (2002) to 5,665 (2009) and those involving 30- to 39-yr-olds 
increased from 77 (2002) to 6,608 (2009). In 2009, the number 
of cases in 40- to 49-yr-old patients also increased from 21 cases 
(2002) to 1,605 cases. In our seroprevalence study, we found that 
88.3% of subjects 20-29 yr of age were antibody negative. In ad-
dition, almost 50% of patients 30-39 yr of age and nearly 20% of 
subjects in the 40-49 and 50-59 age groups were also antibody 
negative. Therefore, public health measures are required for not 
only the young population but also subjects over 40 yr of age.
  The present study has some limitations. First, sera from diag-
nostic laboratories were collected anonymously; therefore, de-
mographic factors, including socioeconomic status, education, 
high-risk activities (alcoholic or drug history, sexual activity, etc.), 
nationality, and crowding index, were not collected. It is neces-
sary to conduct a seroprevalence study on hepatitis A with these 
information included because to the best of our knowledge, no 
studies, including demographic analyses, have been performed 
in Korea. In addition, 75% of the samples were retrieved from 
urban centers in Seoul, Incheon, and Gyeonggi-do. Most labo-
ratory institutions from other provinces are located in an urban 
area, not in a rural district. Hepatitis A seroprevalence reflects 
immunity acquired either through infection or immunization, 
which can differ between regional areas; therefore, these factors 
should be considered when interpreting the results. In a nation-
al survey conducted in 2007 among children 12 months to 6 yr 
of age, the overall vaccination rate for hepatitis A vaccine was 
39.4%, with a regional range from 12% (Chungcheongbuk-do) 
to 59.5% (Ulsan Metropolitan City) according to district (unpub-
lished data). Considering that most of the samples were collect-
ed from urban districts, the seroprevalence data might be un-
derestimated in older age groups (which reflects previous infec-
tion) or overestimated in younger age groups (which reflects an 
opportunity of or interest in vaccination) compared to the gen-
eral population. In addition, differences between regional areas 
were not analyzed because of limited availability of samples from 
various regions. However, the present study included subjects 
1-79 yr of age and samples were collected randomly. Therefore, 
although the data of this study might not be representative of the 
general population, it provides insight into the current pattern 
of immunity against hepatitis A. In previous studies performed 
in Korea, data differed according to study population and age 
classification. However, a review of the data showed a distinct 
shift in seroprevalence patterns; this enhances the comprehen-
sion of epidemiologic changes among subjects from 1 to over Lee H, et al.  •  Seroprevalence of Hepatitis A in Korea
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40 yr (up to the late 70s) and through the decades by comparing 
studies performed at different periods of time. Moreover, we 
could see the impact of the hepatitis A vaccine by comparing 
data from the pre- and post-vaccine period.
  To control a vaccine-preventable disease, it is important to 
identify the population groups susceptible to infection. This can 
be done by surveillance of the disease, including the incidence, 
age distribution of patients, and regional differences. In addition, 
identifying the characteristics and risk factors of the disease pop-
ulation is important in disease control and prevention. Another 
important method is conducting a seroprevalence study com-
paring age groups and regions, in which patterns of particularly 
susceptible groups can be observed. A seroprevalence study re-
flects current and previous vaccination policies, and by confirm-
ing susceptible age groups, seroprevalence studies provide in-
valuable information required for determining national immu-
nization policies and preventing continuous epidemics. In high 
endemic areas, universal immunization is not recommended 
because clinical hepatitis A is usually a minor public health prob-
lem and most children under 10 yr of age experience asymp-
tomatic infections. In areas of intermediate endemicity, wide-
spread vaccination in children and adolescents controls hepa-
titis A infections, whereas in low endemic areas, vaccination in 
high-risk populations is recommended (23). Through this sero-
prevalence study, it is found that Korea is at a status of interme-
diate endemicity; therefore, a universal vaccination program 
would be advisable. 
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Seroepidemiology of Hepatitis A in Korea: Changes over the Past 30 Years
Hyunju Lee, Hye Kyung Cho, Jong-Hyun Kim and Kyung-Hyo Kim
We evaluated the seroprevalence of hepatitis A (HAV) to assess the immune status of the Korean population and find susceptible 
age groups. Residual serum samples from diagnostic laboratories were collected from 2008 to 2010. The seroprevalence of anti-HAV 
was 57.3% in subjects 1-4 yr, 69.8% in 5-9 yr and decreased to 38.8% in 10-14 yr, 13.0% in 15-19 yr and was lowest in the 20-
29 yr age group by 11.7%. Seroprevalence increased with advancing age; 52.2% in 30-39 yr, 83.2% in 40-49 yr, 81.4% in 50-59 
yr, 93.2% in 60-69 yr and 95.1% in 70-79 yr. The susceptible age group proved to be 10-29 yr age, especially 20-29 yr age. 
Related with improvements in hygiene and introduction of hepatitis A vaccine, there has been a shift in age groups of the target 
susceptible population. 